These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33781510)

  • 1. Glioblastoma: Molecular Mechanisms and Clinical Trials.
    Liau LM
    Neurosurg Clin N Am; 2021 Apr; 32(2):xiii. PubMed ID: 33781510
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomic landscape of glioblastoma and the potential clinical utility.
    Wang CJ; Choe KS
    CNS Oncol; 2014 May; 3(3):169-72. PubMed ID: 25055121
    [No Abstract]   [Full Text] [Related]  

  • 3. [Gene therapy of glioblastoma].
    Astrup J
    Ugeskr Laeger; 2001 Apr; 163(15):2147. PubMed ID: 11332215
    [No Abstract]   [Full Text] [Related]  

  • 4. Gene therapeutics: the future of brain tumor therapy?
    Cutter JL; Kurozumi K; Chiocca EA; Kaur B
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1053-64. PubMed ID: 16831077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral therapy for glioblastoma.
    Chiocca EA; Aghi M; Fulci G
    Cancer J; 2003; 9(3):167-79. PubMed ID: 12952302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present trend in the primary treatment of aggressive malignant glioma: glioblastoma multiforme.
    Parvez T
    Technol Cancer Res Treat; 2008 Jun; 7(3):241-8. PubMed ID: 18473496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics boosts brain-cancer work.
    Hayden EC
    Nature; 2010 Jan; 463(7279):278. PubMed ID: 20090720
    [No Abstract]   [Full Text] [Related]  

  • 8. Solving the riddle of glioblastoma: The hope for immunotherapy.
    Bashir R; Mohile NA
    Neurology; 2016 Jun; 86(24):2220-1. PubMed ID: 27225224
    [No Abstract]   [Full Text] [Related]  

  • 9. Clonal diversity in glioblastoma: is it clinically relevant?
    Watts C; Piccirillo SG
    Future Oncol; 2015; 11(12):1703-6. PubMed ID: 26075436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: New Therapeutic Approaches for the Treatment of Glioblastoma.
    Festuccia C; Gravina GL
    Curr Cancer Drug Targets; 2017; 17(3):200-202. PubMed ID: 28322151
    [No Abstract]   [Full Text] [Related]  

  • 11. A silver lining on the horizon for glioblastoma.
    Knisely JP; Baehring JM
    Lancet Oncol; 2009 May; 10(5):434-5. PubMed ID: 19410186
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene and viral therapy for glioblastoma: a review of clinical trials and future directions.
    Mohyeldin A; Chiocca EA
    Cancer J; 2012; 18(1):82-8. PubMed ID: 22290261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in epigenetic glioblastoma therapy.
    Lee DH; Ryu HW; Won HR; Kwon SH
    Oncotarget; 2017 Mar; 8(11):18577-18589. PubMed ID: 28099914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Elderly Patients with Glioblastoma.
    Roth P; Gramatzki D; Weller M
    Curr Neurol Neurosci Rep; 2017 Apr; 17(4):35. PubMed ID: 28324304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for glioblastoma: future perspective for delivery systems and molecular targets.
    Shir A; Levitzki A
    Cell Mol Neurobiol; 2001 Dec; 21(6):645-56. PubMed ID: 12043839
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glioblastoma: Molecular analysis and its clinical implications].
    Castañeda CA; Casavilca S; Orrego E; García-Corrochano P; Deza P; Heinike H; Castillo M; Belmar-Lopez C; Ojeda L
    Rev Peru Med Exp Salud Publica; 2015; 32(2):316-25. PubMed ID: 26338394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular predictors in glioblastoma: toward personalized therapy.
    Colman H; Aldape K
    Arch Neurol; 2008 Jul; 65(7):877-83. PubMed ID: 18625854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype Switching in Glioblastoma Promotes Therapy Escape.
    Cancer Discov; 2023 Mar; 13(3):525. PubMed ID: 36637349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomics illuminates a deadly brain cancer.
    Kuehn BM
    JAMA; 2010 Mar; 303(10):925-7. PubMed ID: 20215599
    [No Abstract]   [Full Text] [Related]  

  • 20. Functional validation confirms genomic phenotypes of glioblastoma with implications for targeted therapy.
    Parsa AT
    World Neurosurg; 2011; 75(5-6):573-4. PubMed ID: 21704908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.